Search research articles
Contact Us
Filters
Showing results (51-60 of 55) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 55 results.
American Journal of Mental Retardation : AJMR
|
October 13, 2006
Longitudinal analysis of the impact and cost of person-centered planning for people with intellectual disabilities in England
Janet Robertson, Eric Emerson, Chris Hatton, et al.
Journal of Intellectual Disabilities : JOID
|
May 22, 2008
Reported goal setting and benefits of person centred planning for people with intellectual disabilities
Sarah Wigham, Janet Robertson, Eric Emerson, et al.
ACS Chemical Biology
|
August 26, 2017
Synthetic Lethality Triggered by Combining Olaparib with BRCA2-Rad51 Disruptors
Federico Falchi, Elisa Giacomini, Tiziana Masini, et al.
European Journal of Medicinal Chemistry
|
January 21, 2019
Rad51/BRCA2 disruptors inhibit homologous recombination and synergize with olaparib in pancreatic cancer cells
Marinella Roberti, Fabrizio Schipani, Greta Bagnolini, et al.
Journal of Medicinal Chemistry
|
February 11, 2020
Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib
Greta Bagnolini, Domenico Milano, Marcella Manerba, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 55) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 55 results.
American Journal of Mental Retardation : AJMR
|
October 13, 2006
Longitudinal analysis of the impact and cost of person-centered planning for people with intellectual disabilities in England
Janet Robertson, Eric Emerson, Chris Hatton, et al.
Journal of Intellectual Disabilities : JOID
|
May 22, 2008
Reported goal setting and benefits of person centred planning for people with intellectual disabilities
Sarah Wigham, Janet Robertson, Eric Emerson, et al.
ACS Chemical Biology
|
August 26, 2017
Synthetic Lethality Triggered by Combining Olaparib with BRCA2-Rad51 Disruptors
Federico Falchi, Elisa Giacomini, Tiziana Masini, et al.
European Journal of Medicinal Chemistry
|
January 21, 2019
Rad51/BRCA2 disruptors inhibit homologous recombination and synergize with olaparib in pancreatic cancer cells
Marinella Roberti, Fabrizio Schipani, Greta Bagnolini, et al.
Journal of Medicinal Chemistry
|
February 11, 2020
Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib
Greta Bagnolini, Domenico Milano, Marcella Manerba, et al.
Page
of 6